Profile
Dr. Coates leads the Health & Human Services portfolio at Decisive Point.
Previously, Dr. Coates was at Bain Capital Life Sciences and a fellow at Harvard Medical School.
He’s worked with small & medium-sized biotech companies on a wide range of clinical challenges, including trial design and execution.
Dr. Coates graduated from McGill University in Chemical & Biomedical Engineering, received an MSc in Nuclear Medicine & Medical Oncology (with honors) from the University of Oxford, and then a PhD in Drug Discovery also from Oxford.
Dr. Coates has published over two dozen peer-reviewed manuscripts and three book chapters that span machine learning, telemetry, and drug discovery.
James Coates active positions
| Companies | Position | Start |
|---|---|---|
Decisive-Point LLC
Decisive-Point LLC Investment ManagersFinance Decisive Point invests in companies located in the United States. The firm focuses on companies operating in deep-tech innovations for security, health, and infrastructure. It provides financing for early-stage capital requirements. | Corporate Officer/Principal | 2021-12-31 |
Training of James Coates
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
University of Oxford
University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
McGill University
McGill University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Decisive-Point LLC
Decisive-Point LLC Investment ManagersFinance Decisive Point invests in companies located in the United States. The firm focuses on companies operating in deep-tech innovations for security, health, and infrastructure. It provides financing for early-stage capital requirements. | Finance |
- Stock Market
- Insiders
- James Coates
















